Walleye Capital’s Zenas BioPharma ZBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBIO
Walleye Capital's ZBIO Position: Q3 2026 in Review
Walleye Capital reduced its Zenas BioPharma (ZBIO) stake by 43% in Q3 2026, selling an estimated $2.76M and leaving 119,551 shares worth $3.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2347.
Walleye Capital first reported a position in ZBIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.31M in Q2 2026. 105 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.
- Walleye Capital held 119,551 shares of Zenas BioPharma worth $3.22M as of Q3 2026.
- Walleye Capital sold 89,499 Zenas BioPharma shares in Q3 2026, an estimated $2.76M.
- Zenas BioPharma made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2347 holding.
- Walleye Capital first reported a position in Zenas BioPharma in Q1 2026 and has held it in 3 quarters since.
- Walleye Capital's Zenas BioPharma position peaked at $5.31M in Q2 2026.
- 105 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.